Analysts: Mylan Inc (MYL.OQ)
MYL.OQ on NASDAQ Stock Exchange Global Select Market
33.99USD
4:00pm EDT
33.99USD
4:00pm EDT
Price Change (% chg)
$0.43 (+1.28%)
$0.43 (+1.28%)
Prev Close
$33.56
$33.56
Open
$33.73
$33.73
Day's High
$34.62
$34.62
Day's Low
$33.54
$33.54
Volume
1,261,976
1,261,976
Avg. Vol
1,207,109
1,207,109
52-wk High
$34.62
$34.62
52-wk Low
$22.51
$22.51
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.87 | December | 1 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 6 | 6 | 6 | 6 |
| (2) OUTPERFORM | 6 | 5 | 5 | 5 |
| (3) HOLD | 6 | 6 | 6 | 7 |
| (4) UNDERPERFORM | 1 | 2 | 2 | 1 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.11 | 2.21 | 2.21 | 2.16 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 13 | 1,894.41 | 1,960.00 | 1,757.00 | 1,876.15 |
| Quarter Ending Dec-13 | 13 | 1,814.94 | 1,913.50 | 1,720.00 | 1,781.43 |
| Year Ending Dec-13 | 18 | 7,068.26 | 7,290.00 | 6,745.00 | 7,186.93 |
| Year Ending Dec-14 | 18 | 7,668.67 | 8,398.00 | 7,113.00 | 7,516.35 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 18 | 0.87 | 0.92 | 0.81 | 0.77 |
| Quarter Ending Dec-13 | 18 | 0.70 | 0.73 | 0.67 | 0.66 |
| Year Ending Dec-13 | 20 | 2.87 | 2.93 | 2.80 | 2.72 |
| Year Ending Dec-14 | 20 | 3.24 | 3.57 | 3.10 | 2.92 |
| LT Growth Rate (%) | 4 | 8.80 | 10.00 | 7.00 | 11.12 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 1,690.16 | 1,631.49 | 58.67 | 3.47 |
| Quarter Ending Dec-12 | 1,728.34 | 1,722.85 | 5.49 | 0.32 |
| Quarter Ending Sep-12 | 1,847.14 | 1,809.77 | 37.37 | 2.02 |
| Quarter Ending Jun-12 | 1,658.68 | 1,677.98 | 19.30 | 1.16 |
| Quarter Ending Mar-12 | 1,583.02 | 1,583.70 | 0.68 | 0.04 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | 0.61 | 0.62 | 0.01 | 0.83 |
| Quarter Ending Dec-12 | 0.64 | 0.65 | 0.01 | 2.19 |
| Quarter Ending Sep-12 | 0.77 | 0.83 | 0.06 | 8.21 |
| Quarter Ending Jun-12 | 0.54 | 0.60 | 0.06 | 10.15 |
| Quarter Ending Mar-12 | 0.50 | 0.52 | 0.02 | 3.28 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 1,894.41 | 1,894.41 | 1,902.30 | 1,904.42 | 1,876.15 |
| Quarter Ending Dec-13 | 1,814.94 | 1,814.94 | 1,817.88 | 1,816.19 | 1,781.43 |
| Year Ending Dec-13 | 7,068.26 | 7,068.26 | 7,076.20 | 7,077.31 | 7,186.93 |
| Year Ending Dec-14 | 7,668.67 | 7,668.67 | 7,703.18 | 7,699.92 | 7,516.35 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 0.87 | 0.87 | 0.87 | 0.88 | 0.77 |
| Quarter Ending Dec-13 | 0.70 | 0.70 | 0.70 | 0.70 | 0.66 |
| Quarter Ending Dec-13 | 2.87 | 2.86 | 2.87 | 2.86 | 2.72 |
| Quarter Ending Dec-14 | 3.24 | 3.23 | 3.23 | 3.23 | 2.92 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 3 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 3 |
| Year Ending Dec-13 | 0 | 0 | 1 | 3 |
| Year Ending Dec-14 | 0 | 0 | 2 | 2 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 3 |
| Quarter Ending Dec-13 | 0 | 0 | 2 | 2 |
| Year Ending Dec-13 | 1 | 0 | 2 | 3 |
| Year Ending Dec-14 | 1 | 0 | 3 | 2 |
- Mylan earnings rise, but dollar drags on revenue
- UPDATE 2-Mylan earnings rise, but dollar drags on revenue
- Mylan second quarter earnings rise, but foreign exchange drags
- Mylan says court dismisses some of Teva's patent claims on MS drug
- Mylan says court dismisses some of Teva's patent claims on MS drug
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Trading Report for (MYL). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: S&P Capital IQ – STARS Reports
|
$127.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates